A Primer on DNA Methylation and Its Potential to Impact Maternal Depression Risk and Assessment During Pregnancy and the Postpartum

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved..

Depression onset during and after pregnancy is prevalent and associated with significant implications for maternal, child, and family health. Although environmental risk factors important to the expression of pregnancy-related depression are well known, knowledge of the genetic underpinning is limited. Given the joint contribution of environmental and genetic factors to depression risk liability, DNA methylation presents itself as an ideal biomarker to investigate basic mechanisms and opportunities for translational research to care for pregnancy-related depression health outcomes. This article is an introduction to DNA methylation and its potential to serve as a marker of depression risk during pregnancy and the postpartum. This commentary discusses current clinical uses of DNA methylation-based testing and how it may be applied to perinatal depression clinical care and management.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:35

Enthalten in:

The Journal of perinatal & neonatal nursing - 35(2021), 1 vom: 01. Jan., Seite 4-7

Sprache:

Englisch

Beteiligte Personen:

Lapato, Dana M [VerfasserIn]
Wolf, Hope M [VerfasserIn]
Lancaster, Eva E [VerfasserIn]
Roberson-Nay, Roxann [VerfasserIn]
York, Timothy P [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Protein Precursors
Receptors, Oxytocin

Anmerkungen:

Date Completed 18.10.2021

Date Revised 18.10.2021

published: Print

Citation Status MEDLINE

doi:

10.1097/JPN.0000000000000528

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM320891534